POM Investment Strategies’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$69.5K Sell
541
-550
-50% -$64.4K 0.08% 75
2026
Q1
$131K Buy
1,091
+731
+203% +$84.4K 0.16% 65
2025
Q4
$37.9K Buy
360
+287
+393% +$26.9K 0.02% 78
2025
Q3
$6.13K Buy
73
+50
+217% +$4.12K ﹤0.01% 130
2025
Q2
$1.82K Sell
23
-9
-28% -$715 ﹤0.01% 112
2025
Q1
$2.87K Sell
32
-116
-78% -$10.8K ﹤0.01% 137
2024
Q4
$14.7K Buy
148
+76
+106% +$7.83K 0.01% 134
2024
Q3
$8.18K Sell
72
-95
-57% -$11.3K 0.01% 146
2024
Q2
$20.7K Buy
167
+135
+422% +$17.4K 0.02% 124
2024
Q1
$4.22K Buy
32
+23
+256% +$2.83K ﹤0.01% 146
2023
Q4
$981 Buy
+9
New +$934 ﹤0.01% 210

Other funds holding MRK

POM Investment Strategies's MRK Position: Q2 2026 in Review

POM Investment Strategies reduced its Merck (MRK) stake by 50% in Q2 2026, selling an estimated $64.4K and leaving 541 shares worth $69.5K. The position accounts for 0.08% of the portfolio, ranked #75.

POM Investment Strategies first reported a position in MRK in Q4 2023 and has held it in 11 quarters since. The position peaked at $131K in Q1 2026. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • POM Investment Strategies held 541 shares of Merck worth $69.5K as of Q2 2026.
  • POM Investment Strategies sold 550 Merck shares in Q2 2026, an estimated $64.4K.
  • Merck made up 0.08% of POM Investment Strategies's portfolio in Q2 2026, its #75 holding.
  • POM Investment Strategies first reported a position in Merck in Q4 2023 and has held it in 11 quarters since.
  • POM Investment Strategies's Merck position peaked at $131K in Q1 2026.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on POM Investment Strategies's 13F filing for Q2 2026, filed 31 Jul 2026.